Sidley Austin represented BigHat Biosciences in the transaction. BigHat Biosciences (BigHat), a biotechnology company with a machine learning (ML)-guided antibody discovery and development platform, announced a...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented BigHat Biosciences, Inc. in the transaction. BigHat Biosciences, Inc. (“BigHat”), announced a licensing collaboration with Synaffix B.V. (“Synaffix”), a Lonza company (SWX:LONN). BigHat’s...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented BigHat Biosciences in the transaction. BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced its collaboration...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BigHat on the transaction. AbbVie Inc. and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences. Section 32, a venture capital fund that invests in frontiers of...
You must be a Standard 1 Year member to access this content.
